Related Experiment Video
Updated: Dec 14, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective
Wheeler Torres1, Manuel Nava1, Nestor Galbán1
1Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
Abstract:
Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has an impact on tissue function. This represents a risk factor for the development of numerous non-transmissible diseases. In consequence, the scientific community continues to search for therapeutic measures capable of improving quality of life and delaying cellular aging. At the center of this research is metformin, a widely used drug in Type 2 Diabetes Mellitus treatment that has a reduced adverse effects profile. Furthermore, there is evidence that this drug has beneficial health effects that go beyond its anti-hyperglycemic properties. Among these effects, its geronto-protection capability stands out. There is growing evidence that points out to an increased life expectancy as well as the quality of life in model organisms treated with metformin. Therefore, there is an abundance of research centered on elucidating the mechanism through which metformin has its anti-aging effects. Among these, the AMPK, mTORC1, SIRT1, FOXO, NF.kB, and DICER1 pathways can be mentioned. Furthermore, studies have highlighted the possibility of a role for the gut microbiome in these processes. The next step is the design of clinical essays that have as a goal evaluating the efficacy and safety of metformin as an anti-aging drug in humans to create a paradigm in the medical horizon. The question being if metformin is, in fact, the new antiaging therapy in humans?
Insights
Metformin, a diabetes drug, shows promise in extending lifespan and improving healthspan in model organisms. Research is exploring its anti-aging mechanisms and potential as a human therapy.
Area of Science:
- Gerontology
- Pharmacology
- Cellular Biology
Background:
- Aging impacts cellular homeostasis and increases non-transmissible disease risk.
- Metformin, a Type 2 Diabetes Mellitus drug, has a favorable safety profile.
- Emerging evidence suggests metformin possesses health benefits beyond glucose control, including geroprotective effects.
Purpose of the Study:
- To investigate metformin's potential as an anti-aging therapy.
- To explore the mechanisms underlying metformin's geroprotective capabilities.
- To assess the potential for clinical trials evaluating metformin's efficacy and safety in humans for anti-aging.
Main Methods:
- Review of existing scientific literature on metformin and aging.
- Analysis of studies in model organisms demonstrating increased lifespan and quality of life with metformin.
- Identification of key molecular pathways implicated in metformin's anti-aging effects.
Main Results:
- Metformin treatment has been linked to increased life expectancy and improved quality of life in various model organisms.
- Key molecular pathways potentially mediating metformin's anti-aging effects include AMPK, mTORC1, SIRT1, FOXO, NF-kB, and DICER1.
- The gut microbiome may play a role in metformin's geroprotective actions.
Conclusions:
- Metformin exhibits significant geroprotective properties in preclinical studies.
- Further research into metformin's anti-aging mechanisms is warranted.
- Clinical trials are necessary to determine metformin's efficacy and safety as an anti-aging intervention in humans.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Mitochondria
Pharmacodynamics in Geriatric Patients: Effects of Age
PI3K/mTOR/AKT Signaling Pathway
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

